BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18492933)

  • 1. AJR teaching file: incidental hepatic mass.
    Beaty SD; Silva AC; Depetris G
    AJR Am J Roentgenol; 2008 Jun; 190(6 Suppl):S62-4. PubMed ID: 18492933
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatocyte targeted MR contrast agent--Gd-BOPTA(E-7155)].
    Kuwatsuru R; Katayama H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():323-7. PubMed ID: 11761966
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatocyte-specific magnetic resonance imaging contrast agents.
    Fidler J; Hough D
    Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
    [No Abstract]   [Full Text] [Related]  

  • 4. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis.
    Fowler KJ; Brown JJ; Narra VR
    Hepatology; 2011 Dec; 54(6):2227-37. PubMed ID: 21932400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MultiHance: help or hype?
    Bartolozzi C; Spinazzi A
    J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S151-9. PubMed ID: 10608411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions.
    Pirovano G; Vanzulli A; Marti-Bonmati L; Grazioli L; Manfredi R; Greco A; Holzknecht N; Daldrup-Link HE; Rummeny E; Hamm B; Arneson V; Imperatori L; Kirchin MA; Spinazzi A
    AJR Am J Roentgenol; 2000 Oct; 175(4):1111-20. PubMed ID: 11000175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis.
    Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
    Clin Imaging; 2008; 32(6):453-9. PubMed ID: 19006774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.
    Jeon TY; Kim SH; Lee WJ; Lim HK
    Abdom Imaging; 2010 Jun; 35(3):337-45. PubMed ID: 19350315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early phase II trial of Gd-BOPTA (E7155) for the MR imaging of liver tumors].
    Kuwatsuru R; Kadoya M; Tanimoto A; Hirohashi S; Katayama H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Jul; 56(8):555-63. PubMed ID: 8797346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver lesion characterization: the wrong choice of contrast agent can mislead the diagnosis of hemangioma.
    Pradella S; Lucarini S; Colagrande S
    AJR Am J Roentgenol; 2012 Nov; 199(5):W662. PubMed ID: 23096214
    [No Abstract]   [Full Text] [Related]  

  • 12. MRI findings of hepatocellular carcinoma.
    Wiwanitkit V
    Magn Reson Imaging; 2011 Feb; 29(2):303. PubMed ID: 21129874
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI.
    Choi SH; Lee JM; Yu NC; Suh KS; Jang JJ; Kim SH; Choi BI
    AJR Am J Roentgenol; 2008 Aug; 191(2):529-36. PubMed ID: 18647927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast enhanced MR-guided biopsy of hepatocellular carcinoma.
    König CW; Trübenbach J; Fritz J; Lauer UM; Claussen CD; Pereira PL
    Abdom Imaging; 2004; 29(1):71-6. PubMed ID: 15160756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple cavernous hemangioma progressing in size in a cirrhotic liver].
    Henninger B; Bale R; Schocke M
    Rofo; 2010 Apr; 182(4):357-9. PubMed ID: 19953432
    [No Abstract]   [Full Text] [Related]  

  • 16. MRI findings of rapidly progressive hepatocellular carcinoma.
    Kierans AS; Leonardou P; Hayashi P; Brubaker LM; Elazzazi M; Shaikh F; Semelka RC
    Magn Reson Imaging; 2010 Jul; 28(6):790-6. PubMed ID: 20427139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
    Zhang HM; Ouyang H; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capsule of hepatocellular carcinoma: where and how does the capsule show enhancement?
    Itai Y
    Radiology; 1999 Feb; 210(2):577-9. PubMed ID: 10207449
    [No Abstract]   [Full Text] [Related]  

  • 19. Case 195: chondrosarcoma of the posterior mediastinum.
    Nasseri F; Chen GJ; Nachiappan AC
    Radiology; 2013 Jul; 268(1):299-303. PubMed ID: 23793593
    [No Abstract]   [Full Text] [Related]  

  • 20. Focal nodular hyperplasia: typical and atypical MRI findings with emphasis on the use of contrast media.
    Marin D; Brancatelli G; Federle MP; Lagalla R; Catalano C; Passariello R; Midiri M; Vilgrain V
    Clin Radiol; 2008 May; 63(5):577-85. PubMed ID: 18374723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.